Comerica (CMA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Werte in diesem Artikel
For the quarter ended March 2025, Comerica Incorporated (CMA) reported revenue of $829 million, up 5.7% over the same period last year. EPS came in at $1.25, compared to $1.29 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $831.98 million, representing a surprise of -0.36%. The company delivered an EPS surprise of +9.65%, with the consensus EPS estimate being $1.14.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Comerica performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Efficiency Ratio: 70.3% versus 71.9% estimated by five analysts on average. Net interest margin: 3.2% versus the five-analyst average estimate of 3.2%. Net charge-offs (recoveries)/Average total loans: 0.2% versus 0.2% estimated by five analysts on average. Average Balance - Total earning assets: $70.38 billion compared to the $71.18 billion average estimate based on four analysts. Total nonperforming assets: $301 million compared to the $314.05 million average estimate based on three analysts. Total nonperforming loans: $301 million compared to the $317.08 million average estimate based on two analysts. Total noninterest income: $254 million compared to the $266.25 million average estimate based on five analysts. Net interest income: $575 million versus $566.88 million estimated by five analysts on average. Service charges on deposit accounts: $46 million compared to the $46.05 million average estimate based on three analysts. Fiduciary income: $52 million compared to the $54.23 million average estimate based on three analysts. Commercial lending fees: $16 million compared to the $17.35 million average estimate based on three analysts. Bank-owned life insurance: $9 million versus $11.03 million estimated by two analysts on average. View all Key Company Metrics for Comerica here>>>Shares of Comerica have returned -10.3% over the past month versus the Zacks S&P 500 composite's -5.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Comerica Incorporated (CMA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Comerica und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Comerica
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Comerica
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Comerica Inc.
Analysen zu Comerica Inc.
Datum | Rating | Analyst | |
---|---|---|---|
15.02.2019 | Comerica Market Perform | BMO Capital Markets | |
02.01.2019 | Comerica Underweight | Barclays Capital | |
10.12.2018 | Comerica Neutral | B. Riley FBR | |
09.04.2018 | Comerica Outperform | Wedbush Morgan Securities Inc. | |
27.03.2018 | Comerica Buy | B. Riley FBR, Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
15.02.2019 | Comerica Market Perform | BMO Capital Markets | |
09.04.2018 | Comerica Outperform | Wedbush Morgan Securities Inc. | |
27.03.2018 | Comerica Buy | B. Riley FBR, Inc. | |
09.02.2018 | Comerica Outperform | BMO Capital Markets | |
18.10.2017 | Comerica Buy | FBR & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
10.12.2018 | Comerica Neutral | B. Riley FBR | |
05.03.2018 | Comerica Neutral | Wedbush Morgan Securities Inc. | |
30.11.2016 | Comerica Neutral | Wedbush Morgan Securities Inc. | |
10.11.2016 | Comerica Neutral | Robert W. Baird & Co. Incorporated | |
19.10.2016 | Comerica Mkt Perform | FBR & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
02.01.2019 | Comerica Underweight | Barclays Capital | |
29.02.2016 | Comerica Underweight | Barclays Capital | |
11.09.2015 | Comerica Underperform | BMO Capital Markets | |
20.05.2015 | Comerica Underperform | Robert W. Baird & Co. Incorporated | |
22.02.2012 | Comerica sell | Stifel, Nicolaus & Co., Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Comerica Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen